Abstract
Bacterial pathogens have become increasingly resistant to commonly used antibiotics. In some cases, there are no remaining first-line options for therapy. Problem pathogens which may cause dermatologic and rheumatologic infections will be discussed, including vancomycin-resistant staphylococci and enterococci as well as the multiply-resistant Gram-negative bacilli. Risk factors for acquisition of these organisms and diagnostic studies available for their detection will be reviewed. The underlying mechanisms of resistance, geographic prevalence, potential for continued spread, and proposed strategies for prevention and control are examined. Finally, information on the newer topical and systemic antimicrobial agents, including investigational therapies, will be presented.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gold, H.S., Moellering, R.C., Jr.: Antimicrobial-drug resistance. New Engl J Med. 335:1445–1453. 1996.
Fraimow, H.S., Abrutyn, E.: Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 9:497–530. 1995.
Bodey, G.P.: Resistance to antimicrobial agents revisited. Current Opinion Infect Dis. 10:419–21. 1997.
Billstein, S.A.: How pharmaceutical companies bring an antibiotic drug to market in the United States. Antimicrob Ag Chemother. 38:2679–82. 1994.
Joshi, N., Milfred, D.: The use and misuse of new antibiotics. Arch Intern Med. 155:569–76. 1995.
Caputo, G.M., Applebaum, P.C., Liu, H.H.: Infections due to penicillin-resistant pneumococci: Clinical, epidemiologic, and microbiologic features. Arch Intern Med. 153:1301–10. 1993.
Tomas, A.: The pneumococcus at the gates. New Engl J Med. 333:5145. 1995.
Doern, G.V., Brueggemann, A., Holley, Jr., H.P., et al: Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Ag Chemother. 40:1208–13. 1996.
Reichmann, P., Konig, A., Linares, J., et al: A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Strepto-coccus pneumoniae. J Infect Dis. 176: 1001–12. 1997.
Musher, D.M.: Streptococcus pneumoniae. In Mandell, G.L., Bennett, J.E., Dolin, R., Principles and Practice of Infectious Diseases, Fourth Edition, p. 1822. Churchill Livingston: New York, 1995.
Fischetti, V.A.: The streptococcus and the host: Present and future challenges. Am Soc Microbiol News. 10:541–5. 1997.
Kiska, D.L., Thiede, B., Caracciolo, J., et al: Invasive Group A streptococcal infections in North Carolina: Epidemiology, clinical features and genetic and serotype analysis of causative organisms. J Infect Dis. 176:992–1000. 1997.
Eliopoulos, G.: Vancomycin-resistant enterococci: Mechanism and clinical relevance. Infect Dis Clin North Am. 11:851–865. 1997.
Husni, R., Raad, I.: Treatment and prevention of vancomycin-resistant enterococcus. Current Opinion Infect Dis. 10:431–4. 1997.
Centers for Disease Control: Reduced susceptibility of Staphylococcus aureus to vancomycin—Japan, 1996. Morbid Mortal Weekly Rept. 46:624–6. 1997.
Williams, D., Bergan, T., Moosden, F.: Arrival of vancomycin resistance in Staphylococcus aureus. Antibiotics Chemother. 1:1. 1997.
Centers for Disease Control: Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. Morbid Mortal Weekly Rept. 46:626–8, 635. 1997.
Jacoby, G.A.: Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am. 11:875–87. 1997.
Sahm, D.F., Tenover, F.C.: Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria. Infect Dis Clin North Am. 11:767–83. 1997.
Jorgensen, J.H.: Laboratory issues in the detection and reporting of antibacterial resistance. Infect Dis Clin North Am. 11:785–802. 1997.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Liu, H.H. (1999). Antibiotic Resistance in Bacteria. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_59
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4857-7_59
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7203-5
Online ISBN: 978-1-4615-4857-7
eBook Packages: Springer Book Archive